FDA-s New “Breakthrough” Designation Allows New Drugs to Gain Approval After Just 1 Round of Testing

Five Star Equities Provides Stock Research on AEterna Zentaris and Amicus Therapeutics

Continue Reading

Long-Term Outlook for Uranium Demand Positive as Approximately 500 Nuclear Reactors Planned/Under Contruction

Five Star Equities Provides Stock Research on Ur-Energy and Uranerz Energy

Continue Reading

Cree and Veeco Instruments Look to Benefit From Surging LED Lighting Market in 2013

Five Star Equities Provides Stock Research on Cree and Veeco Instruments

Continue Reading

Programs by the FDA Designed to Speed up Approval Process for Critical Drugs a Key Factor in Biotech-s Industry Success

Five Star Equities Provides Stock Research on Geron and Threshold Pharmaceuticals,

Continue Reading

LED Lighting Market Forecasted to Experience Steady Growth in 2013

Five Star Equities Provides Stock Research on Aixtron and SemiLEDs

Continue Reading

Biotech Industry Looks to Benefit From FDA-s New “Breakthrough” Designation

Five Star Equities Provides Stock Research on Biosante Pharmaceuticals and ZIOPHARM Oncology

Continue Reading

FDA Programs Designed to Speed Up Approval Process Helps Send Drug Approvals to a 15-Year High in 2012

Five Star Equities Provides Stock Research on Aegerion Pharmaceuticals and Alnylam

Continue Reading

FDA-s New “Breakthrough” Designation Allows New Drugs to Gain Approval After Just 1 Round of Testing

Five Star Equities Provides Stock Research on Idenix Pharmaceuticals and Peregrine Pharmaceuticals

Continue Reading

17 out of 18 U.S. Big Banks Past Latest Round of Stress Tests

Five Star Equities Provides Stock Research on JPMorgan Chase & Co. and Morgan Stanley

Continue Reading

New Programs Designed to Speed Up Approval Process a Key Factor in Biotech Industry-s Growth in 2012

Five Star Equities Provides Stock Research on Halozyme Therapeutics and Novavax

Continue Reading